文献速递主动脉外科

主动脉弓腔内修复:分支与开窗支架设计选择及全球结果

Endovascular Arch Repair: Endograft Design Options and Worldwide Results.
PubMed 文献 · Eur J Cardiothorac Surg · 2025-01-01

本文为叙述性综述,评估分支与开窗胸主动脉腔内修复(B-/F-TEVAR)治疗主动脉弓病变的技术进展与临床结局。B-/F-TEVAR技术成功率高(84%-100%),30天死亡率0%-25%、卒中率3%-36%;开窗修复适用于小弯侧病变且死亡率可低至2%,分支修复适应复杂解剖但部分队列卒中率更高。卒中仍是显著并发症,再干预率提示需关注长期耐久性。

要点

  • B-/F-TEVAR技术成功率高(84%-100%),可用于选定高危主动脉弓病变患者。
  • 30天死亡率0%-25%、卒中率3%-36%,开窗修复死亡率可低至2%。
  • 卒中仍是显著并发症,再干预率提示需长期随访评估耐久性。

核心结论

  • B-/F-TEVAR已成为选定高危主动脉弓病变患者的可行治疗选择,技术成功率高。
  • 卒中仍是显著并发症,再干预率提示需关注长期耐久性。

研究设计与样本

  • 叙述性文献综述,评估分支与开窗胸主动脉腔内修复装置演变及不同患者队列的技术成功、围术期结局与长期性能。

主要发现

  • B-/F-TEVAR技术成功率为84%-100%。
  • 30天死亡率为0%-25%,卒中率为3%-36%。
  • 开窗修复适用于小弯侧病变,部分研究死亡率低至2%。
  • 分支修复对复杂解剖适应性更强,但某些队列卒中率更高。

临床怎么用

  • 对选定高危主动脉弓病变患者可考虑B-/F-TEVAR,需权衡卒中风险与长期耐久性。
  • 开窗修复可优先考虑小弯侧病变,分支修复适用于复杂解剖但需警惕卒中。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This review evaluates procedural and technical advancements in branched and fenestrated thoracic endovascular aortic repair (B-/F-TEVAR) for aortic arch pathologies, with the main focus on the clinical outcomes, including stroke and mortality. METHODS: A narrative review of the literature was conducted to assess the evolution of B-/F-TEVAR devices, including branched and fenestrated designs. Key factors such as technical success, perioperative outcomes, and long-term performance were examined across various patient cohorts, with the focus on mortality and stroke. RESULTS: B-/F-TEVAR achieves high technical success rates (84%-100%), with 30-day mortality and stroke rates typically ranging from 0% to 25% and 3% to 36%, respectively. Fenestrated repairs are particularly suited for pathologies involving the lesser aortic curvature, offering reduced mortality (as low as 2% in some studies), while branched repairs provide greater adaptability for complex anatomies, albeit with higher stroke rates in certain cohorts. CONCLUSIONS: B-/F-TEVAR has emerged as a feasible treatment option for selected high-risk patients with aortic arch pathology, achieving high technical success. Although outcomes may improve with growing experience, stroke remains a significant complication, and reintervention rates highlight the need for long-term durability.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Lescan M, Kondov S, Dimov A, et al. Endovascular Arch Repair: Endograft Design Options and Worldwide Results. Eur J Cardiothorac Surg. 2025. PMID: 40796232. doi:10.1093/ejcts/ezaf273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。